Long-term remission in patients with dermatitis herpetiformis on a normal diet

Br J Dermatol. 2003 Nov;149(5):968-71. doi: 10.1111/j.1365-2133.2003.05579.x.

Abstract

Background: A life-long gluten-free diet is the treatment of choice for dermatitis herpetiformis, which is considered to be coeliac disease of the skin.

Objectives: To investigate the effects on long-term remission of dermatitis herpetiformis in patients who underwent a gluten challenge and subsequently reintroduced dietary gluten.

Patients and methods: We studied 38 patients (14 male and 24 female) with biopsy-confirmed dermatitis herpetiformis. They had followed a gluten-free diet for a mean of 8 years, achieving clinical remission and intestinal normalization. The patients were asked to reintroduce gluten in their diet and agreed to undergo skin and intestinal biopsies during the follow-up.

Results: Of the 38 patients abandoning a gluten-free diet, 31 reported the onset of rash within an average of 2 months. Seven subjects (three males, mean age 15 years at challenge) experienced no clinical or histological relapses (median follow-up 12 years), and lost IgA immunoglobulin from the skin. The two series of patients differed in terms of age at diagnosis (mean age: 26.6 vs. 6 years), the use of dapsone (one of 31 vs. four of seven) and adherence to the gluten-free diet (strict compliance in 26 of 31 vs. none of seven).

Conclusions: Our data suggest that the ingestion of small doses of gluten in childhood and/or the use of an anti-inflammatory drug may modify the immunological response inducing immune tolerance. We report long-term clinical and histological remissions in seven patients with dermatitis herpetiformis after the reintroduction of dietary gluten.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Dapsone / therapeutic use
  • Dermatitis Herpetiformis / diet therapy*
  • Dermatitis Herpetiformis / drug therapy
  • Dermatitis Herpetiformis / immunology
  • Female
  • Follow-Up Studies
  • Glutens / administration & dosage*
  • Glutens / toxicity
  • Histocompatibility Testing
  • Humans
  • Immune Tolerance
  • Male
  • Middle Aged
  • Patient Compliance
  • Recurrence
  • Remission Induction

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Glutens
  • Dapsone